Can PC-9 Zhong chong replace K-1 Yong quan for the acupunctural resuscitation of a bilateral double-amputee? Stating the "random criterion problem" in its statistical analysis.

Aim: To present an inclusion criterion for patients who have suffered bilateral amputation in order to be treated with the supplementary resuscitation treatment which is hereby proposed by the author.

Methods: This work is based on a Retrospective Cohort model so that a certainly lethal risk to the control group is avoided.

Results: This paper presents a hypothesis on acupunctural PC-9 Zhong chong point, further supported by previous statistical work recorded for the K-1 Yong quan resuscitation point.

Drawing the Yongquan protocol into the different stages of the cardiopulmonary resuscitation sequence.

Aim: To introduce new applications into the ILCOR-cardiopulmonary resuscitation (CPR) "chain" sequence.

Methods: Stages of the CPR sequence ("chain"): prior to the application of chest massage: assess the victim's state of consciousness and lung-heart failure; seek help (call 911), or in situations in which it is impossible to start the ILCOR protocol: (1) if the victim is trapped in car crash, overturned car, landslide, massive number of victims or catastrophe; or (2) delayed CPR. During chest compression: Yongquan is simultane- ously stimulated by a third rescuer.

Torsadogenic index: a proposal to improve survival rates in cardiac arrests due to prescribed drugs.

Since unexpected sudden deaths have been reported with the use of diverse non-cardiac drugs, cardio-safety experts focused their attention on security measures to improve survival rates in heart stoppages due to this prescribed drugs (Inchauspe 2010a). Considering that prolongation of the QTc is a reliable marker of a menacing arrhythmia called torsade de pointes (TdP) - that can progress to ventricular fibrillation, application of Bazett, or Rautaharhu formulas can lead to a proper predictive valuation of a "torsadogenic risk." Case-analysis raises up the proposal that QTc or QTp will allow to identify high risk groups; performs a close pharmaco-vigilance and legally register ECG follow-up, avoiding unnecessary withdrawal of useful drugs from market.